Home | Log in or Sign Up for full access | Tracked Organizations | Recent Tracked Activities

Recent Activities

Activities between Nov. 15, 2024, 8:04 p.m. and Nov. 22, 2024, 8:04 p.m. from: Pharmacy Benefit Management Services.

Click on a document link to see the original source document. Click on the name of an organization to see more organization linkages and timelines.


Rightway Partners with Curai Health to Expand Access to High-Quality, Affordable Virtual Care

Document Date: Nov. 21, 2024, 4:15 p.m. / Source: PR Newswire
Activity Class: PartnershipActivity
Partnership: Document Extract: Rightway Partners with Curai Health to Expand Access to High-Quality, Affordable Virtual Care. NEW YORK, Nov. 21, 2024 /PRNewswire/ - Today, Rightway, a company transforming care navigation and pharmacy benefits, announced a strategic partnership with Curai Health, an AI-powered virtual clinic to maximize member outcomes and reduce costs. Members can access Curai for virtual urgent care 24/7 through the Rightway app. Within minutes, members can connect with a Curai MD, DO, or ARNP for diagnosis, treatment, prescriptions, and follow-ups as needed. Rightway nurses ensure seamless post-visit support by coordinating prescriptions, labs, imaging, referrals, and driving members to third-party solutions when applicable to enhance ongoing care.
Document Source: https://www.prnewswire.com/news-releases/rightway-partners-with-curai-health-to-expand-access-to-high-quality-affordable-virtual-care-302313259.html (archive.org page / archive.org listing)


Onco360® Has Been Selected as a National Specialty Pharmacy Partner for Revuforj® (revumenib)

Document Date: Nov. 20, 2024, 9:35 p.m. / Source: GlobeNewswire
Activity Class: PartnershipActivity / Region: Louisville
Partnership: Document Extract: The binding of KMT2A fusion proteins with menin is involved in KMT2A-rearranged acute leukemias through activation of a leukemogenic transcriptional pathway. " Onco360 is grateful for the opportunity to partner with the team at Syndax and add Revuforj® to our comprehensive portfolio of cancer and rare disease therapies ," said Benito Fernandez. The FDA approval of Revuforj® is based on the results of 104 patients with R/R acute leukemias with a KMT2A translocation who were treated with Revumenib in the Phase 1/2 AUGMENT-101 trial. Revuforj administration resulted in a 21.2 % rate of complete remission (CR) plus CR with partial hematologic recovery (CRh) . The most common adverse reactions occurring in ≥20 % of patients consisted of hemorrhage, nausea, increased phosphate, musculoskeletal pain, infection, increased aspartate aminotransferase, febrile neutropenia, increased alanine aminotransferase, increased intact parathyroid hormone, bacterial infection, diarrhea, differentiation syndrome, electrocardiogram QT prolonged, decreased phosphate, increased triglycerides, decreased potassium, decreased appetite, constipation, edema, viral infection, fatigue, and increased alkaline phosphatase.
Document Source: https://www.globenewswire.com/news-release/2024/11/20/2984797/0/en/Onco360-Has-Been-Selected-as-a-National-Specialty-Pharmacy-Partner-for-Revuforj-revumenib.html (archive.org page / archive.org listing)


Chutes & Ladders-Centene president to retire, Abridge and AccessHope tap industry execs

Document Date: Nov. 15, 2024, 8:20 p.m. / Source: Fierce Healthcare
Activity Class: RoleActivity / Type: Finishing
Role: Person: Organization: Document Extract: Centene President Ken Fasola will retire next summer, the insurer revealed in a Securities and Exchange Commission filing this week.
Document Source: https://www.fiercehealthcare.com/digital-health/chutes-ladders (archive.org page / archive.org listing)


PrimeRx Expands Leadership Team, Naming David Kirkus, Pharm.D., as VP of PrimeRx MARKET

Document Date: Nov. 20, 2024, 6:17 p.m. / Source: PR Newswire
Activity Class: RoleActivity / Type: Starting / Region: Uniondale
Role: Person: Organization: Document Extract: UNIONDALE, N.Y., Nov. 20, 2024 /PRNewswire/ - PrimeRx, a leader in pharmacy management software and solutions, is excited to announce the appointment of David Kirkus, Pharm.D., as Vice President of PrimeRx MARKET, effective November 11, 2024.
Document Source: https://www.prnewswire.com/news-releases/primerx-expands-leadership-team-naming-david-kirkus-pharmd-as-vp-of-primerx-market-302311915.html (archive.org page / archive.org listing)


AvevoRx Appoints Cary Goodin as Vice President of Managed Care

Document Date: Nov. 21, 2024, 2 p.m. / Source: prweb
Activity Class: RoleActivity / Type: Starting
Role: Person: Organization: Document Extract: AvevoRx Appoints Cary Goodin as Vice President of Managed Care.
Document Source: https://www.prweb.com/releases/avevorx-appoints-cary-goodin-as-vice-president-of-managed-care-302312771.html (archive.org page / archive.org listing)

Archive.org page links will work if the page has already been archived by archive.org, but we can't guarantee which pages archive.org has archived so far.

Treat sameAsNameOnly relationship as same? Yes (Turn Off)

Site Stats | About (includes privacy and cookie notices)
(c) by 1145, 2023-2024. Data licensed under the Open Database License. Please send an email if you need a non-share-alike license and/or you need API access.